The study of the prevalence and incidence of Parkinson’s disease in different world regions




Parkinson’s disease, prevalence, incidence, international experience


Aim. To study the prevalence and incidence of Parkinson’s disease in 5 world regions and rank them by indexes of the prevalence and incidence.

Materials and methods. Methods of scientific analysis, in particular analytical, statistical methods and the content analysis, were used in this work.

Results. The indicators of the prevalence and incidence of Parkinson’s disease in different countries and regions, as well as for different age groups have been determined. It has been shown that the number of patients with Parkinson’s disease increases exponentially with age, i.e. starting from the age of 55 the number of patients increases sharply. It has been found that one of the factors affecting the prevalence of Parkinson’s disease is the state of the environment, in particular the air pollution.

Conclusions. According to the study conducted it has been determined that Parkinson’s disease is spreading unevenly in the world and in individual countries. The data obtained will be used for further research of Parkinson’s disease.


1. Blin, P., Dureau-Pournin, C., Foubert-Samier, A., Grolleau, A., Corbillon, E., Jové, J., Lassalle, R., Robinson, P., Poutignat, N., Droz-Perroteau, C., Moore, N. (2014). Parkinson’s disease incidence and prevalence assessment in France using the national healthcare insurance database. European Journal of Neurology, 22(3), 464–471. doi: 10.1111/ene.12592.

2. Razdorskaya, V. V., Voskresenskaya, O. N., Yudina, G. K. (2016). Bolezn Parkinsona v Rosii: Rasprostranennost i zabolevaemost. Saratov Journal of Medical Scientific Research, 12(3), 379–384.

3. Duncan, G. W., Khoo, T. K., Coleman, S. Y. et al. (2014). The incidence of Parkinson’s disease in the North-East of England. Age and Ageing, 43(2), 257–263. doi: 10.1093/ageing/aft091

4. Pupillo, E., Cricelli, C., Mazzoleni, F., Cricelli, I., Pasqua, A., Pecchioli, S., Lapi, F., Beghi, E. (2016). Epidemiology of Parkinson’s Disease: A Population-Based Study in Primary Care in Italy. Neuroepidemiology, 47(1), 38–45. doi: 10.1159/000448402.

5. Nerius, M., Fink, A., Doblhammer, G. (2017). Parkinson’s disease in Germany: prevalence and incidence based on health claims data. Acta Neurologica Scandinavica, 136(5), 386–392. doi: 10.1111/ane.12694.

6. Nerius, M., Fink, A., Doblhammer-Reiter, G. (2015). Parkinson’s Disease in Germany: Prevalence, Incidence and Mortality Based on Health Claims Data. Rostock Center – Discussion Paper, 32, 4–21.

7. Horsfall, L., Petersen, I., Walters, K., Schrag, A. (2012). Time trends inincidence of Parkinson’s disease diagnosis in UK primary care. Journal of Neurology, 260(5), 1351–1357. doi: 10.1007/s00415-012-6804-z.

8. Liu, C., Li, C., Lee, P., Sun, Y. (2016). Variations in Incidence and Prevalence of Parkinson’s Disease in Taiwan: A Population-Based Nationwide Study. Parkinson’s Disease, 2016, 1–8. doi: 10.1155/2016/8756359.

9. Akanova, A., Kamenova, S., Pichkhadze, G. (2014). Vestnik KazNMU, 4, 441–444.

10. Ma, C., Su, L., Xie, J., Long, J., Wu, P., Gu, L. (2014). The prevalence and incidence of Parkinson’s disease in China: a systematic review and meta-analysis. Journal of Neural Transmission, 121(2), 123–134. doi: 10.1007/s00702-013-1092-z.

11. Van Den Eeden, S., Tanner, C. M., Bernstein, A. L. et al. (2003). Incidence of Parkinson’s Disease: Variation by Age, Gender, and Race/Ethnicity. American Journal of Epidemiology, 157(11), 1015–1022. doi: 10.1093/aje/kwg068.

12. Mehta, P., Kifley, A., Wang, J., Rochtchina, E., Mitchell, P., Sue, C. (2007). Population prevalence and incidence of Parkinson’s disease in an Australian community. Internal Medicine Journal, 37(12), 812–814. doi: 10.1111/j.1445-5994.2007.01433.x.

13. Statistic’s of Parkinson’s disease Canada. Retrieved from:

14. Wong, S., Gilmour, H. andRamage-Morin, P. (2014). Parkinson’s disease: Prevalence, diagnosis and impact. Health Reports, 25(11), 10–14.

15. Caradoc-Davies, T., Weatherall, M., Dixon, G., Caradoc-Davies, G., Hantz, P. (1992). Is the prevalence of Parkinson’s disease in New Zealand really changing? Acta Neurologica Scandinavica, 86(1), 40–44. doi: 10.1111/j.1600-0404.1992.tb08051.x.

16. Okubadejo, N., Bower, J., Rocca, W., Maraganore, D. (2006). Parkinson’s disease in Africa: A systematic review of epidemiologic and genetic studies. Movement Disorders, 21(12), 2150–2156. doi: 10.1002/mds.21153.

17. Badry, R., Nagiub, H., Farghaly, W., Shehata, G., Rageh, T., Abdel-Hakeem, N., Abd Al Hamed, M., Badry, R. (2013). Prevalence of Parkinson’s disease and other types of Parkinsonism in Al Kharga district, Egypt. Neuropsychiatric Disease and Treatment, 9, 1821–1826. doi: 10.2147/NDT.S483181821.

18. Akinyemi, R. (2012). Epidemiology of Parkinsonism and Parkinson’s disease in Sub-Saharan Africa: Nigerian profile. Journal of Neurosciences in Rural Practice, 3(3), 233–234. doi: 10.4103/0976-3147.102586.





Social marketing and pharmacoeconomic research